Literature DB >> 15665370

Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!

V Vedantham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15665370      PMCID： PMC1772497          DOI： 10.1136/bjo.2004.054007

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  Vancomycin and ceftazidime incompatibility upon intravitreal injection.

Authors:  T Lifshitz; R Lapid-Gortzak; Y Finkelman; I Klemperer
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

2.  Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

Authors:  G Galloway; A Ramsay; K Jordan; A Vivian
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Macular infarction after intravitreal amikacin.

Authors:  B H Doft; M Barza
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

4.  Intravitreal delivery of ciprofloxacin.

Authors:  D P Hainsworth; J D Conklin; J R Bierly; D Ax; P Ashton
Journal:  J Ocul Pharmacol Ther       Date:  1996       Impact factor: 2.671

5.  Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates.

Authors:  A R Anand; K L Therese; H N Madhavan
Journal:  Indian J Ophthalmol       Date:  2000-06       Impact factor: 1.848

6.  An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: implications for use in treating endophthalmitis.

Authors:  Alvin K H Kwok; Mamie Hui; Chi Pui Pang; Raphael C Y Chan; Siu Wai Cheung; Cynthia M S Yip; Dennis S C Lam; Augustine F B Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

7.  An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous.

Authors:  M Hui; A K H Kwok; C P Pang; S W Cheung; R C Y Chan; D S C Lam; A F B Cheng
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638
  7 in total
  1 in total

1.  Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis.

Authors:  Nidhi Relhan; Avinash Pathengay; Stephen G Schwartz; Harry W Flynn
Journal:  Retina       Date:  2017-05       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.